These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7027200)

  • 1. [Blood insulin and glucose in essential hypertension treated with prazosin].
    Kokot F; Sledziński Z; Mleczko Z
    Pol Arch Med Wewn; 1981 Jul; 66(1):43-50. PubMed ID: 7027200
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose metabolism during long-term treatment with prazosin.
    Lithell H; Berne C; Waern AU; Wibell L
    Diabetes Res; 1985 Nov; 2(6):297-9. PubMed ID: 3907930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of terazosin and nitrendipine on blood insulin, glucose and lipid in SHR rats].
    Wang W
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Aug; 21(4):234-5. PubMed ID: 7910793
    [No Abstract]   [Full Text] [Related]  

  • 4. [Behavior of C-peptide, insulin and glucose levels in blood during conditions of evaluating selected antihypertensive drugs in patients with hypertension and non-insulin-dependent diabetes (type 2)].
    Jasik M; Kasperska-Dworak A; Czyzyk A
    Pol Arch Med Wewn; 1993 Jun; 89(6):445-55. PubMed ID: 8415207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemorheologic changes in patients with essential hypertension treated with prazosin].
    Gerc V; Koblar V; Brkić D; Kamhi J
    Med Pregl; 1992; 45(7-8):285-7. PubMed ID: 1344459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum lipids in patients with hypertension treated with prazosin].
    Bukowska H; Torbus-Lisiecka B; Pieczul-Mróz J; Gregorczyk J; Wesołowska T
    Pol Arch Med Wewn; 1986 Jul; 76(1):1-6. PubMed ID: 3808984
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin response to oral glucose in essential hypertensives with increased circulating levels of insulin growth factor I.
    Diez J; Ruilope LM; Rodicio JL
    J Hypertens Suppl; 1991 Dec; 9(6):S174-5. PubMed ID: 1818930
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of prazosin on blood pressure and lipid status in patients with arterial hypertension].
    Celikić S; Orozović V; Dimcić Z
    Vojnosanit Pregl; 1985; 42(4):270-3. PubMed ID: 4072052
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of hypertension with prezosin in aged diabetics].
    Königstein RP
    Wien Med Wochenschr; 1978; 128 Suppl 1():27-30. PubMed ID: 636451
    [No Abstract]   [Full Text] [Related]  

  • 10. [Insulin and C-peptide levels in patients with idiopathic arterial hypertension].
    Kinalska I; Borejszo I; Gosiewska A; Laudański T
    Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):579-82. PubMed ID: 1488331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of cilazapril and prazosin on insulin sensitivity in patients with essential hypertension].
    Cirić J; Zarković M; Trbojević B; Tasić N; Nesović M
    Med Pregl; 1995; 48(9-10):326-8. PubMed ID: 8628189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Control of hyperinsulinemia in essential hypertension using the angiotensin-converting enzyme inhibitor, lisinopril].
    Umnerová V; Jarolím M; Jindra A; Jáchymová M; Peleska J; Savlíková J; Stolba P; Horký K
    Cor Vasa; 1993; 35(2):75-9. PubMed ID: 8388786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pressure and metabolic effects of terazosin in essential hypertension].
    Valle R; Semplicini A; Serena L; Gebbin A; Fontebasso A; Gerardi G; De Toni R; Pessina AC
    Cardiologia; 1994 Jun; 39(6):421-4. PubMed ID: 7923256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension and insulin resistance are not directly related in obese dogs.
    Rocchini AP; Yang JQ; Gokee A
    Hypertension; 2004 May; 43(5):1011-6. PubMed ID: 15007033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The assessment of glucose tolerance in hypertensive subjects treated with amlodipine].
    Panuccio D; Romani A; Trabatti MR; Romanelli R; Nardi R
    Clin Ter; 1993 Oct; 143(4):309-13. PubMed ID: 8258265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of prazosin on serum lipids, lipoproteins and apo-lipoproteins in patients with hypertension].
    Sznajderman M; Bednarska M; Niegowska J; Makowiecka-Cieśla M; Cybulska I; Sznajderman M
    Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1657-60. PubMed ID: 3268819
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence of decreased plasma substance P levels in human essential hypertension and influence of prazosin treatment.
    Faulhaber HD; Rathsack R; Rostock G; Homuth V; Pfeiffer D; Naumann E; Hartrodt W; Görne RC; Oehme P
    Biomed Biochim Acta; 1983; 42(7-8):1019-25. PubMed ID: 6197065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of long term prazosin treatment on secretion of insulin, glucagon, gastrin, and pancreatic polypeptide in patients with essential hypertension].
    Zukowska-Szczechowska E; Grzeszczak W; Kokot F; Wiecek A
    Pol Arch Med Wewn; 1993 Jan; 89(1):38-45. PubMed ID: 8479941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the efficacy and tolerance of three antihypertensive agents used as single-drug therapy, nifedipine, prazosin and acebutolol in severe, idiopathic hypertension in adolescents].
    Cichocka E; Januszewicz P; Wyszynska T
    Ann Pediatr (Paris); 1993 Feb; 40(2):119-26. PubMed ID: 8457132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in blood viscosity accompanying the response to prazosin in patients with essential hypertension.
    Letcher RL; Chien S; Laragh JH
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S8-20. PubMed ID: 94641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.